CD109 influences key inflammatory pathways, including TGF-β/NF-κB, EGF/STAT3, and various inflammatory cytokines like IL-6 and IL-8, impacting inflammatory processes such as immune cell recruitment, macrophage polarization, immune microenvironment, EMT, and tumor progression. The gene discussed is NFKB1; the disease is neoplasm.